OpenAlex
PricingAboutJobs
Log inGet started
Work

Empagliflozin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Linagliptin and Metformin: A 24-Week Randomized, Double-Blind, Parallel-Group Trial

HTML

Year: 2016
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Care
DOI: 10.2337/dc16-1347
Authors: Eirik Søfteland, Juris J. Meier, Bente Vangen, Robert Toorawa, Mario Maldonado-Lutomirsky, Uli C. Broedl
Institutions: Haukeland University Hospital, Ruhr University Bochum, Boehringer Ingelheim (Norway), Boehringer Ingelheim (United Kingdom), Boehringer Ingelheim (Germany)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: empagliflozin, type 2 diabetes, adjunctive therapy, linagliptin, metformin, inadequate glycemic control, HbA1c, SGLT2 inhibitors, fasting blood glucose, weight loss, adverse events, drug safety, DPP-4 inhibitors, combination therapy, dose comparison, renal safety, hypoglycemia
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2558145946
FWCI: 9.228
Cites: 24
Cited by: 138
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security